相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。T follicular helper cells and their impact on humoral responses during pathogen and vaccine challenge
Jennifer A. Juno et al.
CURRENT OPINION IN IMMUNOLOGY (2022)
Influenza vaccines: where we are, where we are going
Nadim Khalil et al.
CURRENT OPINION IN PEDIATRICS (2022)
Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron
Jinyan Liu et al.
NATURE (2022)
Development of a Mouse Model to Explore CD4 T Cell Specificity, Phenotype, and Recruitment to the Lung after Influenza B Infection
Ajitanuj Rattan et al.
PATHOGENS (2022)
T cell responses to SARS-CoV-2 spike cross-recognize Omicron
Roanne Keeton et al.
NATURE (2022)
CD4+ Cytotoxic T cells - Phenotype, Function and Transcriptional Networks Controlling Their Differentiation Pathways
Teresa Preglej et al.
IMMUNOLOGY LETTERS (2022)
Tissue resident memory T cells- A new benchmark for the induction of vaccine-induced mucosal immunity
Mariah Hassert et al.
FRONTIERS IN IMMUNOLOGY (2022)
Count on us: T cells in SARS-CoV-2 infection and vaccination
Katherine Kedzierska et al.
CELL REPORTS MEDICINE (2022)
Potentiating Lung Mucosal Immunity Through Intranasal Vaccination
Sean A. Nelson et al.
FRONTIERS IN IMMUNOLOGY (2021)
SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19
Alba Grifoni et al.
CELL HOST & MICROBE (2021)
Intranasal Nanoparticle Vaccination Elicits a Persistent, Polyfunctional CD4 T Cell Response in the Murine Lung Specific for a Highly Conserved Influenza Virus Antigen That Is Sufficient To Mediate Protection from Influenza Virus Challenge
Sean A. Nelson et al.
JOURNAL OF VIROLOGY (2021)
Development of combination adjuvant for efficient T cell and antibody response induction against protein antigen
Yasunari Haseda et al.
PLOS ONE (2021)
Targeting Antigens for Universal Influenza Vaccine Development
Quyen-Thi Nguyen et al.
VIRUSES-BASEL (2021)
M2e-Based Influenza Vaccines with Nucleoprotein: A Review
Mei Peng Tan et al.
VACCINES (2021)
Is a Universal Influenza Virus Vaccine Possible?
Raffael Nachbagauer et al.
ANNUAL REVIEW OF MEDICINE, VOL 71, 2020 (2020)
A Computationally Optimized Broadly Reactive Antigen Subtype-Specific Influenza Vaccine Strategy Elicits Unique Potent Broadly Neutralizing Antibodies against Hemagglutinin
Giuseppe A. Sautto et al.
JOURNAL OF IMMUNOLOGY (2020)
Squalene emulsion-based vaccine adjuvants stimulate CD8 T cell, but not antibody responses, through a RIPK3-dependent pathway
Eui Ho Kim et al.
ELIFE (2020)
Immunomodulation to enhance the efficacy of an HPV therapeutic vaccine
Claire Smalley Rumfield et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Influenza Neuraminidase: A Neglected Protein and Its Potential for a Better Influenza Vaccine
Luca T. Giurgea et al.
VACCINES (2020)
Vaccination of aged mice with adjuvanted recombinant influenza nucleoprotein enhances protective immunity
Tres Cookenham et al.
VACCINE (2020)
T follicular helper cell heterogeneity: Time, space, and function
Wenzhi Song et al.
IMMUNOLOGICAL REVIEWS (2019)
Current and future influenza vaccines
Seiya Yamayoshi et al.
NATURE MEDICINE (2019)
Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages
Kizzmekia S. Corbett et al.
MBIO (2019)
Broadly protective influenza vaccines: design and production platforms
Husni Elbahesh et al.
CURRENT OPINION IN VIROLOGY (2019)
Antigen Priming with Enantiospecific Cationic Lipid Nanoparticles Induces Potent Antitumor CTL Responses through Novel Induction of a Type I IFN Response
Siva K. Gandhapudi et al.
JOURNAL OF IMMUNOLOGY (2019)
Intranodal administration of mRNA encoding nucleoprotein provides cross-strain immunity against influenza in mice
Patrick Tjok Joe et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Computationally optimized broadly reactive vaccine based upon swine H1N1 influenza hemagglutinin sequences protects against both swine and human isolated viruses
Amanda L. Skarlupka et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
An Inactivated Influenza Virus Vaccine Approach to Targeting the Conserved Hemagglutinin Stalk and M2e Domains
Weina Sun et al.
VACCINES (2019)
Peptide Epitope Hot Spots of CD4 T Cell Recognition Within Influenza Hemagglutinin During the Primary Response to Infection
Zackery A. G. Knowlden et al.
PATHOGENS (2019)
With a Little Help from T Follicular Helper Friends: Humoral Immunity to Influenza Vaccination
Marios Koutsakos et al.
JOURNAL OF IMMUNOLOGY (2019)
M2e-based universal influenza vaccines: a historical overview and new approaches to development
Daria Mezhenskaya et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
Overcoming Barriers in the Path to a Universal Influenza Virus Vaccine
Lynda Coughlan et al.
CELL HOST & MICROBE (2018)
Vaccine options for influenza: thinking small
Bert Schepens et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
Neuraminidase as an influenza vaccine antigen: a low hanging fruit, ready for picking to improve vaccine effectiveness
Maryna C. Eichelberger et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
Distinct and complementary roles of CD4 T cells in protective immunity to influenza virus
Andrea J. Sant et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
CD4 T cells in protection from influenza virus: Viral antigen specificity and functional potential
Andrea J. Sant et al.
IMMUNOLOGICAL REVIEWS (2018)
CD4 T Cell Epitope Specificity and Cytokine Potential Are Preserved as Cells Transition from the Lung Vasculature to Lung Tissue following Influenza Virus Infection
Anthony DiPiazza et al.
JOURNAL OF VIROLOGY (2018)
Influenza Virus: Dealing with a Drifting and Shifting Pathogen
Hyunsuh Kim et al.
VIRAL IMMUNOLOGY (2018)
Broadly protective anti-hemagglutinin stalk antibodies induced by live attenuated influenza vaccine expressing chimeric hemagglutinin
Irina Isakova-Sivak et al.
VIROLOGY (2018)
Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine
E. Bridie Clemens et al.
VACCINES (2018)
Combining R-DOTAP and a particulate antigen delivery platform to trigger dendritic cell activation: Formulation development and in-vitro interaction studies
Markus Riehl et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Cytotoxic CD4 T Cells-Friend or Foe during Viral Infection?
Jennifer A. Juno et al.
FRONTIERS IN IMMUNOLOGY (2017)
CD4 CTL, a Cytotoxic Subset of CD4+ T Cells, Their Differentiation and Function
Arata Takeuchi et al.
FRONTIERS IN IMMUNOLOGY (2017)
T cell-dependent antigen adjuvanted with DOTAP-CpG-B but not DOTAP-CpG-A induces robust germinal center responses and high affinity antibodies in mice
Munir Akkaya et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Avian and Human Seasonal Influenza Hemagglutinin Proteins Elicit CD4 T Cell Responses That Are Comparable in Epitope Abundance and Diversity
Anthony DiPiazza et al.
CLINICAL AND VACCINE IMMUNOLOGY (2017)
Follicular Helper T Cells
Carola G. Vinuesa et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 34 (2016)
Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?
Karlynn E. Neu et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Recombinant hemagglutinin influenza vaccine provides broader spectrum protection
Lisa M. Dunkle et al.
EXPERT REVIEW OF VACCINES (2016)
Poly (I:C)-DOTAP cationic nanoliposome containing multi-epitope HER2-derived peptide promotes vaccine-elicited anti-tumor immunity in a murine model
Ghazal Alipour Talesh et al.
IMMUNOLOGY LETTERS (2016)
The Quest for a Universal Flu Vaccine: Headless HA 2.0
Florian Krammer
CELL HOST & MICROBE (2015)
Cocktail of H5N1 COBRA HA vaccines elicit protective antibodies against H5N1 viruses from multiple clades
Corey J. Crevar et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
In the Shadow of Hemagglutinin: A Growing Interest in Influenza Viral Neuraminidase and Its Role as a Vaccine Antigen
Teddy John Wohlbold et al.
VIRUSES-BASEL (2014)
Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy
Wei Liao et al.
IMMUNITY (2013)
Adjuvants and Immunization Strategies to Induce Influenza Virus Hemagglutinin Stalk Antibodies
Peter H. Goff et al.
PLOS ONE (2013)
Enantiospecific adjuvant activity of cationic lipid DOTAP in cancer vaccine
Elizabeth A. Vasievich et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
The first influenza pandemic of the new millennium
Gabriele Neumann et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2011)
Infection with Seasonal Influenza Virus Elicits CD4 T Cells Specific for Genetically Conserved Epitopes That Can Be Rapidly Mobilized for Protective Immunity to Pandemic H1N1 Influenza Virus
Shabnam Alam et al.
JOURNAL OF VIROLOGY (2011)
Assessment of Seasonal Influenza A Virus-Specific CD4 T-Cell Responses to 2009 Pandemic H1N1 Swine-Origin Influenza A Virus
Xinhui Ge et al.
JOURNAL OF VIROLOGY (2010)
2009 H1N1 Influenza
Seth J. Sullivan et al.
MAYO CLINIC PROCEEDINGS (2010)
Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain
John Steel et al.
MBIO (2010)
FluBlok, a recombinant hemagglutinin influenza vaccine
Manon M. J. Cox et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2008)
A simple but effective cancer vaccine consisting of an antigen and a cationic lipid
Weihsu Chen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Mechanism of adjuvant activity of cationic liposome: Phosphorylation of a MAP kinase, ERK and induction of chemokines
Weili Yan et al.
MOLECULAR IMMUNOLOGY (2007)
Direct ex vivo analyses of HLA-DR1 transgenci mice reveal an exceptionaly broad pattern of immunodominance in the primary HLA-DR1-restricted CD4 T-cell response to influenza virus hemagglutinin
Katherine A. Richards et al.
JOURNAL OF VIROLOGY (2007)
To knockout in 129 or in C57BL/6: that is the question
E Seong et al.
TRENDS IN GENETICS (2004)
分享论文
